View More Recent Stories

Oct 3, 2024 07:31AM Elevai Biosciences, a Subsidiary of Elevai Labs (ELAB), Expands Patent Portfolio
Oct 2, 2024 08:30AM Elevai Labs (ELAB) Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
Sep 23, 2024 08:45AM Elevai Labs (ELAB) Prices 28.57M Share Offering at $0.38/sh
Sep 16, 2024 06:53AM Elevai Labs (ELAB) Files for 28.37M Share and Warrant Offering
Sep 10, 2024 07:31AM Elevai Labs' (ELAB) Elevai Skincare Reports Positive Results for E-Series Exosome Technology in Potential Melasma Applications
Sep 3, 2024 07:30AM Elevai Labs (ELAB) Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
Aug 28, 2024 07:30AM Elevai Labs (ELAB) Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology
Aug 26, 2024 07:30AM Elevai Labs (ELAB) Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
Aug 19, 2024 09:01AM Elevai Labs (ELAB) Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
View More Recent Stories